PURPOSE: To identify comorbidities associated with increased rates of functional decline in persons with lower-extremity peripheral arterial disease (PAD). We also determined whether female sex and black race were associated with greater functional decline than male sex and white race, respectively, in PAD. METHODS: Three-hundred ninety-seven men and women with PAD were followed prospectively for a median of 36 months. The presence of comorbid illnesses was determined with medical record review, patient report, medications, laboratory values, and a primary care physician questionnaire. Functional outcomes, measured annually, included the 6-minute walk, usual-paced and fast-paced 4-meter walking speed, and summary performance score. The summary performance score is a composite measure of lower-extremity functioning (score range, 0 to 12; 12 = best). RESULTS: Adjusting for known and potential confounders, PAD patients with pulmonary disease had a significantly greater average annual decline in 6-minute walk performance of -34.02 ft/y (95% confidence interval [CI], -60.42 to -7.63; P = .012), rapid-paced 4-meter walk speed of -0.028 m/s/y (95% CI, -0.054 to -0.001; P = .042), and summary performance score of -0.460/y (95% CI, -0.762 to -0.157; P = .003) compared with those without pulmonary disease. PAD patients with spinal stenosis had a greater average annual decline in 6-minute walk performance of -77.4 ft/y (95% CI, -18.9 to -35.8; P < .001) and usual-paced 4-meter walking velocity of -0.045 m/s/y (95% CI, -0.081 to -0.009; P = .014) compared with participants without spinal stenosis. CONCLUSION: At 3-year follow-up, pulmonary disease and spinal stenosis were each associated with a significant decline in functioning among persons with PAD. In contrast, female sex and black race were not associated with functional decline among persons with PAD.
PURPOSE: To identify comorbidities associated with increased rates of functional decline in persons with lower-extremity peripheral arterial disease (PAD). We also determined whether female sex and black race were associated with greater functional decline than male sex and white race, respectively, in PAD. METHODS: Three-hundred ninety-seven men and women with PAD were followed prospectively for a median of 36 months. The presence of comorbid illnesses was determined with medical record review, patient report, medications, laboratory values, and a primary care physician questionnaire. Functional outcomes, measured annually, included the 6-minute walk, usual-paced and fast-paced 4-meter walking speed, and summary performance score. The summary performance score is a composite measure of lower-extremity functioning (score range, 0 to 12; 12 = best). RESULTS: Adjusting for known and potential confounders, PAD patients with pulmonary disease had a significantly greater average annual decline in 6-minute walk performance of -34.02 ft/y (95% confidence interval [CI], -60.42 to -7.63; P = .012), rapid-paced 4-meter walk speed of -0.028 m/s/y (95% CI, -0.054 to -0.001; P = .042), and summary performance score of -0.460/y (95% CI, -0.762 to -0.157; P = .003) compared with those without pulmonary disease. PAD patients with spinal stenosis had a greater average annual decline in 6-minute walk performance of -77.4 ft/y (95% CI, -18.9 to -35.8; P < .001) and usual-paced 4-meter walking velocity of -0.045 m/s/y (95% CI, -0.081 to -0.009; P = .014) compared with participants without spinal stenosis. CONCLUSION: At 3-year follow-up, pulmonary disease and spinal stenosis were each associated with a significant decline in functioning among persons with PAD. In contrast, female sex and black race were not associated with functional decline among persons with PAD.
Authors: Nima Toosizadeh; Hannah Stocker; Rebecca Thiede; Jane Mohler; Joseph L Mills; Bijan Najafi Journal: Vasc Med Date: 2016-09-15 Impact factor: 3.239
Authors: James E Graham; Glenn V Ostir; Yong-Fang Kuo; Steven R Fisher; Kenneth J Ottenbacher Journal: Arch Phys Med Rehabil Date: 2008-05 Impact factor: 3.966
Authors: Simon Hsu; Dena E Rifkin; Michael H Criqui; Natalie C Suder; Pranav Garimella; Charles Ginsberg; Antoinette M Marasco; Belinda J McQuaide; Emma J Barinas-Mitchell; Matthew A Allison; Christina L Wassel; Joachim H Ix Journal: J Vasc Surg Date: 2017-12-22 Impact factor: 4.268
Authors: Christina L Wassel; Cecilia Berardi; James S Pankow; Nicholas B Larson; Paul A Decker; Naomi Q Hanson; Michael Y Tsai; Michael H Criqui; Matthew A Allison; Suzette J Bielinski Journal: Atherosclerosis Date: 2015-01-28 Impact factor: 5.162
Authors: Christina L Wassel; Rohit Loomba; Joachim H Ix; Matthew A Allison; Julie O Denenberg; Michael H Criqui Journal: J Am Coll Cardiol Date: 2011-09-20 Impact factor: 24.094
Authors: Mary M McDermott; Luigi Ferrucci; Kiang Liu; Jack M Guralnik; Lu Tian; Melina Kibbe; Yihua Liao; Huimin Tao; Michael H Criqui Journal: J Am Coll Cardiol Date: 2011-02-08 Impact factor: 24.094
Authors: Christina L Wassel; Matthew A Allison; Joachim H Ix; Dena E Rifkin; Nketi I Forbang; Julie O Denenberg; Michael H Criqui Journal: J Vasc Surg Date: 2016-04-29 Impact factor: 4.268
Authors: Bernice Ruo; Kiang Liu; Lu Tian; Jin Tan; Luigi Ferrucci; Jack M Guralnik; Mary M McDermott Journal: Psychosom Med Date: 2007-06-07 Impact factor: 4.312